Primary source: Health Canada
Health Canada announced a recall for Omnipod Insulin Management System due to product performance issues.
Product performance issues may lead to insulin delivery errors, posing serious health risks to users.
Identify affected lots and implement recall procedures as per Health Canada guidelines.
Regulatory Intelligence Lead
action required within 24 hours
Identify affected lots and implement recall procedures as per Health Canada guidelines.
Recall for Omnipod Insulin Management System due to product performance issues.
What changed: Health Canada announced a recall for Omnipod Insulin Management System due to product performance issues.
Why it matters: Product performance issues may lead to insulin delivery errors, posing serious health risks to users.
Practical implication: Identify affected lots and implement recall procedures as per Health Canada guidelines.
Published from the Firecrawl agent regulatory extraction pipeline.
Review and update labeling processes in accordance with the newly published safety-related changes for affected products.
MAHs must allocate resources to develop and maintain SPPs, ensuring they meet the new regulatory requirements and are ready for submission within two days upon request in crisis situations.
Implementation of new dosing schedules and an emphasis on monitoring for potential adverse reactions as outlined in the prescribing information.
Regulatory compliance processes may need updates to incorporate the new recombinant endotoxins testing method and guidelines established under the ICMRA framework.
